Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in  Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial

ConclusionsTDM-guided dose optimization of tamoxifen is estimated to save costs and increase QALYs for early breast cancer patients.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research